His primary areas of investigation include Cell biology, Apoptosis, Molecular biology, Transcription factor and Programmed cell death. His Cell biology research incorporates themes from Cancer cell and Receptor. In most of his Apoptosis studies, his work intersects topics such as Tumor necrosis factor alpha.
The various areas that Colin S. Duckett examines in his Programmed cell death study include Autophagy and Hedgehog signaling pathway. His XIAP study combines topics from a wide range of disciplines, such as Inhibitor of apoptosis and Baculoviral IAP repeat-containing protein 3. His Inhibitor of apoptosis study integrates concerns from other disciplines, such as Regulation of gene expression, Binding site, Function and Gene family.
Cell biology, Apoptosis, Inhibitor of apoptosis, XIAP and Caspase are his primary areas of study. The Cell biology study which covers Cell cycle that intersects with Chromatin. His Apoptosis research is multidisciplinary, incorporating perspectives in Cell culture and Cancer research.
His Inhibitor of apoptosis research is multidisciplinary, incorporating elements of Autocrine signalling, Downregulation and upregulation, Gene, Molecular biology and NLRP1. His XIAP research incorporates elements of Ubiquitin ligase, Inhibitor of apoptosis domain, HtrA serine peptidase 2 and XIAP Deficiency. His research in Caspase intersects with topics in Binding protein, Cytochrome c, Transfection, TRAF2 and Bcl-2-associated X protein.
Colin S. Duckett mainly investigates Inhibitor of apoptosis, XIAP, Cell biology, Cancer research and Apoptosis. The Inhibitor of apoptosis study combines topics in areas such as Caspase and Molecular biology. His studies in XIAP integrate themes in fields like Ubiquitin, Ubiquitin ligase and XIAP Deficiency.
The study incorporates disciplines such as Cell and Necroptosis in addition to Cell biology. His Cancer research study incorporates themes from Heat shock protein, Hsp90, Protein degradation, RIPK1 and CFLAR. His studies deal with areas such as CD30 and Chimera as well as Apoptosis.
Colin S. Duckett spends much of his time researching Inhibitor of apoptosis, Ubiquitin, Ubiquitin ligase, Caspase and XIAP. His research integrates issues of Caspase 10 and Cell culture in his study of Inhibitor of apoptosis. His Ubiquitin study combines topics in areas such as Enzyme activator and Chaperone.
He has included themes like Cancer research, Cell signaling, Signal transduction, Cell biology and XIAP Deficiency in his Ubiquitin ligase study. His work carried out in the field of Caspase brings together such families of science as Molecular biology, Caspase 1 and Gene.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
IAP proteins: blocking the road to death's door
Guy S. Salvesen;Colin S. Duckett.
Nature Reviews Molecular Cell Biology (2002)
A conserved family of cellular genes related to the baculovirus iap gene and encoding apoptosis inhibitors.
C S Duckett;V E Nava;R W Gedrich;R J Clem.
The EMBO Journal (1996)
Molecular mechanisms of cell death: recommendations of the Nomenclature Committee on Cell Death 2018
Lorenzo Galluzzi;Ilio Vitale;Stuart A. Aaronson;John M. Abrams.
Nature (2018)
Characterization of XIAP-Deficient Mice
Helena Harlin;Stephanie Birkey Reffey;Colin S. Duckett;Tullia Lindsten.
Molecular and Cellular Biology (2001)
A cooperative interaction between NF-kappa B and Sp1 is required for HIV-1 enhancer activation.
N.D. Perkins;N.L. Edwards;C.S. Duckett;A.B. Agranoff.
The EMBO Journal (1993)
Cloning of an NF-κB subunit which stimulates HIV transcription in synergy with p65
Roland M. Schmid;Neil D. Perkins;Colin S. Duckett;Philip C. Andrews.
Nature (1991)
Differential Role for TLR3 in Respiratory Syncytial Virus-Induced Chemokine Expression
Brian D. Rudd;Ezra Burstein;Colin S. Duckett;Xiaoxia Li.
Journal of Virology (2005)
CD30-dependent degradation of TRAF2: implications for negative regulation of TRAF signaling and the control of cell survival
Colin S. Duckett;Craig B. Thompson.
Genes & Development (1997)
Distinct combinations of NF-kappa B subunits determine the specificity of transcriptional activation.
Neil D. Perkins;Roland M. Schmid;Colin S. Duckett;Kwanyee Leung.
Proceedings of the National Academy of Sciences of the United States of America (1992)
Altered lymphocyte responses and cytokine production in mice deficient in the X-linked lymphoproliferative disease gene SH2D1A/DSHP/SAP
Michael J. Czar;Ellen N. Kersh;Lilia A. Mijares;Gibson Lanier.
Proceedings of the National Academy of Sciences of the United States of America (2001)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
ModeX Therapeutics
Newcastle University
University Medical Center Groningen
Memorial Sloan Kettering Cancer Center
University of Liverpool
University College London
National Institutes of Health
Technion – Israel Institute of Technology
Karolinska Institute
Walter and Eliza Hall Institute of Medical Research
University of Alicante
University of Iowa
University of Toronto
University of Molise
University of Malaga
University of Lille
Discovery Institute
University of Arizona
Arizona State University
University of Manchester
Hospital for Special Surgery
Oxford Brookes University
Yale University
Kumamoto University
Vita-Salute San Raffaele University
Monash University